Berenberg Starts Seattle Genetics (SGEN) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to Berenberg Starts Seattle Genetics (SGEN) at Buy

Seattle Genetics (SGEN) Reports Complete Enrollment in Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer

March 29, 2019 8:06 AM EDT

Seattle Genetics, Inc. (NASDAQ: SGEN) today announced completion of enrollment in the potentially pivotal innovaTV 204 phase 2 clinical trial evaluating the efficacy, safety and tolerability of tisotumab vedotin as monotherapy for patients with recurrent and/or metastatic cervical cancer who have relapsed or progressed after standard of care treatment. Tisotumab vedotin is being developed... More

Seattle Genetics (SGEN), Astellas Pharma Inc. Report Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer

March 28, 2019 5:56 AM EDT

Seattle Genetics, Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. today announced positive topline results... More